Literature DB >> 22018721

Clinical and cellular characterization of two novel MPZ mutations, p.I135M and p.Q187PfsX63.

Kon-Ping Lin1, Bing-Wen Soong, Ming-Hong Chang, Wei-Ta Chen, Jer-Li Lin, Wei-Ju Lee, Yi-Chung Lee.   

Abstract

OBJECTIVES: We report the clinical and cellular phenotypes of two novel MPZ mutations associated with CMT1B.
METHODS: The two families were evaluated clinically, electrophysiologically, and genetically. The wild-type and mutant P(0) fused with fluorescent proteins were expressed in vitro to monitor their intracellular trafficking. Adhesion assay was also performed to evaluate the adhesiveness of cells.
RESULTS: The two novel heterozygous MPZ mutations, p.I135M and p.Q187PfsX63, are associated with a childhood-onset demyelinating polyneuropathy. The median motor nerve conduction velocities of the two index patients carrying each mutation were 12.9 and 13.6m/s, respectively. Fluorescence analysis demonstrated that the P(0) I135M protein was located on the cell membrane, but the P(0) Q187PfsX63 protein was retained ectopically in the endoplasmic reticulum and Golgi apparatus. Adhesion assay demonstrated a defective adhesiveness of cells expressing either mutant P(0) protein, and P(0) Q187PfsX63 had a more prominent defect of self-adhesive ability than P(0) I135M.
CONCLUSIONS: This study expanded the spectrum of the MPZ mutations and revealed two disparate mechanisms of MPZ mutations associated with a typical CMT1B phenotype. Other modifying genetic, epigenetic, or environmental factors on CMT1B may exist to explain the discrepancy between the cellular phenotypes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018721     DOI: 10.1016/j.clineuro.2011.09.015

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype.

Authors:  Ilaria Callegari; C Gemelli; A Geroldi; F Veneri; P Mandich; M D'Antonio; D Pareyson; M E Shy; A Schenone; V Prada; M Grandis
Journal:  J Neurol       Date:  2019-07-05       Impact factor: 4.849

Review 2.  Intermediate Charcot-Marie-Tooth disease.

Authors:  Lei Liu; Ruxu Zhang
Journal:  Neurosci Bull       Date:  2014-10-17       Impact factor: 5.203

Review 3.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

4.  Two Novel Myelin Protein Zero Mutations in a Group of Chinese Patients.

Authors:  Bin Chen; Zaiqiang Zhang; Na Chen; Wei Li; Hua Pan; Xingao Wang; Yuting Ren; Yuzhi Shi; Hongfei Tai; Songtao Niu
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

5.  Polarization and myelination in myelinating glia.

Authors:  Toshihiro Masaki
Journal:  ISRN Neurol       Date:  2012-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.